Expression of Recombinant Antibody Fragment, Anti BNP-SCFV on the Periplasm of Escherichia Coli for the Detection of Heart Failure

Shabarni Gaffar, Sofyan Multazam N Aji, Yeni W Hartati, Safri Ishmayana, Toto Subroto


Basic natriuretic peptide (BNP) is a polypeptide hormone consist of 32 amino acids that secreted by the heart ventricle to respond the excessive stretching of heart muscle cells. BNP can be used as prognostic marker for patients with heart failure. The presence of BNP in blood can be detected by BNP antibody, which is anti BNP-single chain variable fragment (Anti BNP-SCFV). The antibody is a combination of polypeptides between varying region on the heavy chain (VH) and the light chain (VL) of immunoglobulin. Anti BNP-SCFV will bind to BNP through the antigen-antibody interaction. Concentration of BNP in a patientâs blood can be detected through the interaction of BNP with Anti BNP-SCFV using immunosensor method. Production of recombinant Anti BNP-SCFV in Escherichia coli as host is reported in the present study. Anti BNP-SCFV was expressed in fusion form with OmpC signal peptide that direct the protein to a periplasmic space. Expression was performed under RhaBad promoter as control using L-rhamnose as inducer. SDS-PAGE characterization showed consistent band at 28 kDa, which was assumed as Anti BNP-SCFV. The optimum expression was found at four hours after induction with 4 mM inducer. Anti BNP-SCFV was secreted from the cell as characterized by the presence of the protein on periplasmic membrane and extracellular fraction.


Anti BNP-SCFV, pheriplasmic, Escherichia coli, BNP

Full Text:

View Counter: Abstract = 59 (times), and PDF = 31 (times)


Bach H., Mazor Y., Shaky S., Shoham-Lev A., Berdichevsky Y., Gutnick D.L., Benhar I. 2001. Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single chain antibodies. J. Mol. Biol. 312:79â93.

Cardarelli R., Lumicao T.G.Jr. 2003. B-type natriuretic peptide: a review of its diagnostic, prognostic, and therapeutic monitoring value in heart failure for primary care physicians. J. Am. Board. Fam. Pract. 16:327â333

Francis, G.S., J.P. Gassler & E.H. Sonnenblick. 2005. Pathophysiology and Diagnosis of Heart Failure. In: Fusler V, Alexander RW, OâRourke RA (ed). The Heart 10th ed.1: 655-85.

Gaffar S, Masyhuri A.A, Hartati Y.W, Rustaman. In silico study of single chain variable fragment (SCFV) selective to B-type Natriuretic Peptide (BNP) hormone (submitted)

Gonzales, M.F., T. Brooks, S.U. Pukatzki, & D. Provenzano. 2013. Rapid protocol for preparation of electrocompetent Escherichia coli and Vibrio cholera. Journal of Visualized Experiments. 80:1-6.

Hayden M.S., Gilliland L.K., Ledbetter J.A. 1997. Antibody engineering. Curr. Opin. Immunol. 9:201â212.

Kotzsch A, Vernet E, Hammarstrom M, Berthelsen J, Weigelt J,Graslund S, and Michael Sundstrom. 2011. A secretory system for bacterial production of high-profile protein targets. Protein Science. 20: 597-609.

Kudva, R., K. Denks, P. Kuhn, A. Vogt, M. Muller & H.G. Koch.2013. Translocation Across The Inner Membrane of Gram-Negatif Bacteria: The Sec and Tat Dependent Protein Transport Pathways. Research in Microbiology.164:505-534.

Longenecker, K.L., Ruan Q., Fry E.H., Saldana S.C., Brophy S.E., Richardson P.L. &Tetin S.Y. 2009. Crystal Structure and Thermodynamic Analysis of Diagnostic Mab 106.3 Complexed with BNP 5â13 (C10A). Proteins.76: 536â547.

Maeng, B.H., D.H. Nam, Y.H & Kim, Y.H. 2012. Functional expression of recombinant anti-BNP scFv in methylotrophic yeast Pichia pastoris and application as a recognition molecule in electrochemical sensors. World Journal of Microbiology and Biotechnology.28(3), pp.1027â1034.

Maeng B.H., Nam D.H., Kim Y.H. 2011. Coexpression of molecular chaperones to enhance functional expression of anti-BNP SCFV in the cytoplasm of Escherichia coli for the detection of B-type natriuretic peptide. World. J. Microbiol. Biotechnol. 27:1391â1398.

Maisel, A. 2001. B-Type Natriuretic Peptide Measurements in Diagnosing Congestive Heart Failure in the Dyspneic Emergency Department Patient. Cardiovascular Medicine.3 : 10-17.

Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., Maisel A. 2002. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardio 39(2):202â209

Mueller C., Scholer A., Laule-Kilian K., Martina B., Schindler C., Buser P., Pfisterer M., Perruchoud A.P. 2004. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N. Engl. J. Med. 350:647â654.

Prehna, G., G. Zhang, X. Gong, M. Duszyk, M. Okon, L.P. McIntosh, J.H. Weiner & N.C.J. Strynadka. 2012. A Protein Export Pathway Involving Escherichia coli Porins. Structure. 20:1154-1166.

Quan S., Hiniker A., Collet J. F., Bardwell J. 2013. Isolation of Bacteria Envelope Proteins. Method in Molecular Biology. 966:

Tanfous, N.G.B., Kallel H., Jarboui M.A. & Fathallah D.M. 2006. Expression in Pichia pastoris of a recombinant scFv form of MAb 107, an anti human CD11b integrin antibody. Enzyme Microb. Technol. 38, 636â642.



  • There are currently no refbacks.

Creative Commons License
Jurnal Ilmiah Kimia Molekul by Department of Chemistry, Faculty of Mathematics and Natural Sciences, Universitas Jenderal Soedirman, Purwokerto, Indonesia is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at
Permissions beyond the scope of this license may be available at